A Phase I First-in-Human Study of ABBV-011, a Seizure-Related Homolog Protein 6-Targeting Antibody-Drug Conjugate, in Patients with Small Cell Lung Cancer.

Morgensztern D, Ready N, Johnson ML, Dowlati A, Choudhury N, Carbone DP, Schaefer E, Arnold SM, Puri S, Piotrowska Z, Hegde A, Chiang AC, Iams W, Tolcher A, Nosaki K, Kozuki T, Li T, Santana-Davila R, Akamatsu H, Murakami H, Yokouchi H, Wang S, Zha J, Li R, Robinson RR, Hingorani P, Jeng EE, Furqan M.

Open source

DOI: 10.1158/1078-0432.ccr-24-1547
Published: 2024-11-01
Container: Clin Cancer Res
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1158/1078-0432.ccr-24-1547,
  title = {A Phase I First-in-Human Study of ABBV-011, a Seizure-Related Homolog Protein 6-Targeting Antibody-Drug Conjugate, in Patients with Small Cell Lung Cancer.},
  author = {Morgensztern D and  Ready N and  Johnson ML and  Dowlati A and  Choudhury N and  Carbone DP and  Schaefer E and  Arnold SM and  Puri S and  Piotrowska Z and  Hegde A and  Chiang AC and  Iams W and  Tolcher A and  Nosaki K and  Kozuki T and  Li T and  Santana-Davila R and  Akamatsu H and  Murakami H and  Yokouchi H and  Wang S and  Zha J and  Li R and  Robinson RR and  Hingorani P and  Jeng EE and  Furqan M.},
  year = {2024},
  journal = {Clin Cancer Res},
  doi = {10.1158/1078-0432.ccr-24-1547},
  url = {https://doi.org/10.1158/1078-0432.ccr-24-1547}
}

RIS

TY  - JOUR
TI  - A Phase I First-in-Human Study of ABBV-011, a Seizure-Related Homolog Protein 6-Targeting Antibody-Drug Conjugate, in Patients with Small Cell Lung Cancer.
AU  - Morgensztern D
AU  -  Ready N
AU  -  Johnson ML
AU  -  Dowlati A
AU  -  Choudhury N
AU  -  Carbone DP
AU  -  Schaefer E
AU  -  Arnold SM
AU  -  Puri S
AU  -  Piotrowska Z
AU  -  Hegde A
AU  -  Chiang AC
AU  -  Iams W
AU  -  Tolcher A
AU  -  Nosaki K
AU  -  Kozuki T
AU  -  Li T
AU  -  Santana-Davila R
AU  -  Akamatsu H
AU  -  Murakami H
AU  -  Yokouchi H
AU  -  Wang S
AU  -  Zha J
AU  -  Li R
AU  -  Robinson RR
AU  -  Hingorani P
AU  -  Jeng EE
AU  -  Furqan M.
PY  - 2024
JO  - Clin Cancer Res
DO  - 10.1158/1078-0432.ccr-24-1547
UR  - https://doi.org/10.1158/1078-0432.ccr-24-1547
ER  -

APA

D, M., N, R., ML, J., A, D., N, C., DP, C., E, S., SM, A., S, P., Z, P., A, H., AC, C., W, I., A, T., K, N., T, K., T, L., R, S., H, A., H, M., H, Y., S, W., J, Z., R, L., RR, R., P, H., EE, J., & M., F. (2024). A Phase I First-in-Human Study of ABBV-011, a Seizure-Related Homolog Protein 6-Targeting Antibody-Drug Conjugate, in Patients with Small Cell Lung Cancer.. Clin Cancer Res. https://doi.org/10.1158/1078-0432.ccr-24-1547

Source records

europe-pmc · retrieved 2026-09-27T06:22:25.700Z